Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study

In order to determine whether HR-HPV E6/E7 mRNA testing more effectively predicts precancerous lesions and invasive cervical cancer than HR-HPV DNA testing, we aimed to compare

Also, previous data on HPV mRNA testing in the triage of ASC-US and LSIL[11,25] show that the HPV mRNA test, due to a high specificity and positive predictive value (PPV), is

In the retrospective cohort study (n=655), among 154 women with a history of mood disorder at baseline, 13 (8.5%) developed incident cancer during follow-up, whereas among 501

A recent prospective cohort study using data from the UK Million Women Study with more than 14 years of follow-up reported that asthma requiring treatment was associated with

Repeat cytology, HPV DNA testing (Roche Cobas 4800), and HPV mRNA testing (NorChip PreTect HPV-Proofer) were used to follow up 575 women aged 25–69 years with ASC- US / LSIL in

The current study demonstrated the high HPV/HIV co-infection of 24.4%, with high hr-HPV prevalence across almost all age groups and more multiple hr- HPV infection in HIV-positive

Participants: After excluding women with a history of abnormal smears and with cervical intraepithelial neoplasia grade 2 (CIN2+) before or until 3 months after screening, 11 220

During the study period, the Norwegian Cervical Cancer Screening Programme (NCCSP) recommended delayed triage of women with minor cervical lesions with repeat cytology and HPV